Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AK-006 by Allakos for Chronic Urticaria Or Hives: Likelihood of Approval
AK-006 is under clinical development by Allakos and currently in Phase I for Chronic Urticaria Or Hives. According to GlobalData,...